Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Amplia teams up with big pharma for lung cancer trial
Melbourne-based ASX listed biotech Amplia Therapeutics has secured a major collaboration with pharmaceutical goliath Eli Lilly & Company to evaluate a new combination therapy aimed at tackling non-small cell lung cancer (NSCLC). The two companies…
Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
This article is for subscribers only. Hi, it's Ashleigh Furlong in London and Sonja Wind in Frankfurt, looking at the immediate reaction to news of a potential megamerger in the global pharmaceuticals industry. Also today, Italy's Prysmian extends…
Breakfast News: Pharma's $400B Blockbuster Brewing
Fuel cell maker Bloom Energy (BE -0.63%) entered the Supernova Odyssey portfolio in December, just as it was becoming a critical supplier of power generation to the data center buildout. Following a drawdown from its November 2025 high, the stock…
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
AstraZeneca has had merger talks with Bristol-Myers Squibb, according to the Financial Times. Why it matters: A tie-up would create the world's fourth most valuable drugmaker, with around $400 billion in combined market cap. Investor reax:…
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A 'Head Scratcher'
The Financial Times reported overnight that AstraZeneca has explored acquiring Bristol Myers Squibb in a potential megadeal that would create one of the world's largest drugmakers, with a combined market capitalization of nearly $400 billion. The…
GSK Pharma Q1 profit up 16% at ₹237.18 cr
GlaxoSmithKline Pharmaceuticals Ltd on Monday reported a 16 per cent rise in consolidated net profit to ₹237.18 crore in the first quarter ended June 30, 2026. The company had posted a consolidated net profit of ₹205 crore in the…
Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details
Drugmaker Sun Pharmaceutical Industries has undertaken a voluntary recall of some of its ophthalmic products in the domestic market, with reports suggesting that 11 eyedrops were withdrawn. While the voluntary action is being appreciated, public…
Iran talks, crude crash fuel midday rally; IT joins financials at the top, pharma bleeds
Markets held firm through the first half of Monday's session, with the Sensex trading at 78,719.67, up 625.03 points or 0.80 per cent, and the Nifty 50 at 24,588.35, up 204.75 points or 0.84 per cent, as of 1.30 PM. The gains, which built on a…
Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
Benchmarks opened sharply higher on Monday, August 3, 2026, as easing geopolitical tensions in West Asia and a fall in crude oil prices lifted investor sentiment across the financial and consumer sectors, even as pharmaceutical and auto stocks…
Carmignac Gestion Purchases Shares of 631,200 Royalty Pharma PLC $RPRX
Carmignac Gestion purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased…
Defilade Capital Management L.P. Lowers Position in Ascendis Pharma A/S $ASND
Defilade Capital Management L.P. lessened its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 39.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0811 GMT – A potential tie-up between AstraZeneca and Bristol Myers Squibb could face antitrust hurdles…
New Yorker: China races to own the industries of the future
America has been napping or distracted by trivialities while China is racing toward the future, in part by taking advantage of President Trump's trade, immigration and budget policies. That's the eye-opening reality that Evan Osnos unfurls in a…
Musi river sediment free of hazardous material, says MRDCL; activists dispute claim
The sediment in the Musi River stretch between the twin reservoirs and Bapughat, earmarked for development under Phase I of the Musi Riverfront Development Project, is free of hazardous material, the authorities of Musi Riverfront Development…
Receive a Daily briefing on Pharma Industry News
Get Started